Common dysfunctional variants in ABCG2 are a major cause of early-onset gout
- PMID: 23774753
- PMCID: PMC3684804
- DOI: 10.1038/srep02014
Common dysfunctional variants in ABCG2 are a major cause of early-onset gout
Abstract
Gout is a common disease which mostly occurs after middle age, but more people nowadays develop it before the age of thirty. We investigated whether common dysfunction of ABCG2, a high-capacity urate transporter which regulates serum uric acid levels, causes early-onset gout. 705 Japanese male gout cases with onset age data and 1,887 male controls were genotyped, and the ABCG2 functions which are estimated by its genotype combination were determined. The onset age was 6.5 years earlier with severe ABCG2 dysfunction than with normal ABCG2 function (P = 6.14 × 10(-3)). Patients with mild to severe ABCG2 dysfunction accounted for 88.2% of early-onset cases (twenties or younger). Severe ABCG2 dysfunction particularly increased the risk of early-onset gout (odds ratio 22.2, P = 4.66 × 10(-6)). Our finding that common dysfunction of ABCG2 is a major cause of early-onset gout will serve to improve earlier prevention and therapy for high-risk individuals.
Conflict of interest statement
H.M., K.I., T.T., T.N., H.S. and N.S. have a patent pending based on the work reported in this paper. The other authors declare no competing financial interests.
Figures


Similar articles
-
Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.Int J Mol Sci. 2021 Feb 16;22(4):1935. doi: 10.3390/ijms22041935. Int J Mol Sci. 2021. PMID: 33669292 Free PMC article.
-
Identification of ABCG2 dysfunction as a major factor contributing to gout.Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1098-104. doi: 10.1080/15257770.2011.627902. Nucleosides Nucleotides Nucleic Acids. 2011. PMID: 22132963
-
ABCG2/BCRP dysfunction as a major cause of gout.Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1117-28. doi: 10.1080/15257770.2011.633954. Nucleosides Nucleotides Nucleic Acids. 2011. PMID: 22132966
-
ABCG2 as a therapeutic target candidate for gout.Expert Opin Ther Targets. 2018 Feb;22(2):123-129. doi: 10.1080/14728222.2018.1420167. Epub 2017 Dec 28. Expert Opin Ther Targets. 2018. PMID: 29264928 Review.
-
[Recent progress and prospects for research on urate efflux transporter ABCG2].Nihon Rinsho. 2014 Apr;72(4):757-65. Nihon Rinsho. 2014. PMID: 24796111 Review. Japanese.
Cited by
-
Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.Int J Mol Sci. 2021 Feb 16;22(4):1935. doi: 10.3390/ijms22041935. Int J Mol Sci. 2021. PMID: 33669292 Free PMC article.
-
Identification of four genes as novel susceptibility loci for early-onset type 2 diabetes mellitus, metabolic syndrome, or hyperuricemia.Biomed Rep. 2018 Jul;9(1):21-36. doi: 10.3892/br.2018.1105. Epub 2018 May 29. Biomed Rep. 2018. PMID: 29930802 Free PMC article.
-
Genetic variation in the ABCG2 gene is associated with gout risk in the Chinese Han population.Clin Rheumatol. 2016 Jan;35(1):159-63. doi: 10.1007/s10067-015-3105-9. Epub 2015 Oct 27. Clin Rheumatol. 2016. PMID: 26506822
-
Identification of rs671, a common variant of ALDH2, as a gout susceptibility locus.Sci Rep. 2016 May 16;6:25360. doi: 10.1038/srep25360. Sci Rep. 2016. PMID: 27181629 Free PMC article.
-
Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway.Nutr Metab (Lond). 2021 Jun 18;18(1):63. doi: 10.1186/s12986-021-00583-y. Nutr Metab (Lond). 2021. PMID: 34144706 Free PMC article.
References
-
- Cannon P. J., Stason W. B., Demartini F. E., Sommers S. C. & Laragh J. H. Hyperuricemia in primary and renal hypertension. N. Engl. J. Med. 275, 457–464 (1966). - PubMed
-
- Tuttle K. R., Short R. A. & Johnson R. J. Sex differences in uric acid and risk factors for coronary artery disease. Am. J. Cardiol. 87, 1411–1414 (2001). - PubMed
-
- Lin Y. H. et al. Gouty arthritis in acute cerebrovascular disease. Cerebrovasc. Dis. 28, 391–396 (2009). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical